Advertisement

Nicotine Interventions with Comorbid Populations

  • Sharon M. Hall
    Correspondence
    Address correspondence and reprint requests to: Sharon M. Hall, PhD, University of California, San Francisco, 401 Parnassus Avenue, Box 0984, San Francisco CA 94143-0984.
    Affiliations
    Department of Health Psychology, University of California, San Francisco, San Francisco, California
    Search for articles by this author

      Abstract

      This article reviews and comments on studies of treatment and prevention of cigarette smoking in individuals with comorbid psychiatric and non-nicotine substance abuse disorders. Despite a high prevalence of cigarette smoking in these populations and interest in quitting, treatment interventions and studies of these interventions are sparse. Multiple barriers to implementation of interventions exist. Existing data suggest that provision of cigarette-smoking interventions in substance abuse treatment patients is efficacious and does not appear to interfere with abstinence from alcohol or illicit drugs, but more research is needed. There are few studies in populations with psychiatric disorders, with the exception of studies of individuals with a history of major depressive disorder. The available data suggest at least moderate efficacy and little evidence of exacerbation of these disorders. Integration of interventions into existing treatment clinics appears desirable. Despite the identification of subgroups that are especially likely to adopt cigarette smoking, there have been no targeted prevention efforts. Further research is recommended in both the treatment and prevention of cigarette smoking in individuals with psychiatric and substance abuse disorders. It is reasonable to offer existing treatments to these subgroups of smokers, since there is some evidence of efficacy and little evidence of harm.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hurt R.D.
        • Offord K.P.
        Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort.
        JAMA. 1996; 275: 1097-1102
        • Lasser K.
        • Boyd J.W.
        • Woolhandler S.
        • Himmelstein D.U.
        • McCormick D.
        • Bor D.H.
        Smoking and mental illness: A population-based prevalence study.
        JAMA. 2000; 284: 2606-2610
        • Grant B.F.
        • Hasin D.S.
        • Chou S.P.
        • Stinson F.S.
        • Dawson D.A.
        Nicotine dependence and psychiatric disorders in the U.S.: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
        Arch Gen Psychiatry. 2004; 61: 1107-1115
        • Hughes J.R.
        Comorbidity and smoking.
        Nicotine Tob Res. 1999; 1: S149-S152
        • Hughes J.R.
        • Hatsukami D.K.
        • Mitchell J.E.
        • Dahlgren L.A.
        Prevalence of smoking among psychiatric outpatients.
        Am J Psychiatry. 1986; 143: 993-997
        • Prochaska J.J.
        • Gill P.
        • Hall S.M.
        Treatment of tobacco use in an inpatient psychiatric setting.
        Psychiatr Serv. 2004; 55: 1265-1270
        • Acton G.S.
        • Prochaska J.J.
        • Kaplan A.S.
        • Small T.
        • Hall S.M.
        Depression and stages of change for smoking in psychiatric outpatients.
        Addict Behav. 2001; 26: 621-631
        • Kalman D.
        Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice.
        Subst Use Misuse. 1998; 33: 2021-2047
        • Clemmey P.
        • Brooner R.
        • Chutuape M.A.
        • Kidorf M.
        • Stitzer M.
        Smoking habits and attitudes in a methadone maintenance treatment population.
        Drug Alcohol Depend. 1997; 44: 123-132
        • Prochaska J.J.
        • Delucchi K.
        • Hall S.M.
        A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.
        J Consult Clin Psychol. 2004; 72: 1144-1156
        • Zevin S.
        • Benowitz N.L.
        Drug interactions with tobacco smoking: an update.
        Clin Pharmacokinet. 1999; 36: 425-438
        • Hertling I.
        • Ramskogler K.
        • Dvorak A.
        • et al.
        Craving and other characteristics of the comorbidity of alcohol and nicotine dependence.
        Eur Psychiatry. 2005; 20: 442-450
        • Bobo J.K.
        • Slade J.
        • Hoffman A.
        Nicotine addiction counseling for chemically dependent patients.
        Psychiatr Serv. 1995; 46: 945-947
        • Hahn E.J.
        • Warnick T.
        • Plemmons S.
        Smoking cessation in drug treatment programs.
        J Addict Dis. 1999; 18: 89-101
        • Bobo J.K.
        Nicotine dependence and alcoholism epidemiology and treatment.
        J. Psychoactive Drugs. 1992; 24: 123-129
      1. Hall SM. Commentary. Paper presented at: VA in the Vanguard: Building on Success in Smoking Cessation, 2004; San Francisco CA.

        • Prochaska J.J.
        • Fromont S.C.
        • Hall S.M.
        How prepared are psychiatry residents for treating nicotine dependence?.
        Acad Psychiatry. 2005; 29: 256-261
        • Glassman A.H.
        Cigarette smoking: implications for psychiatric illness.
        Am J Psychiatry. 1993; 150: 546-553
        • Hughes J.R.
        • Zarin D.A.
        • Pincus H.A.
        Treating nicotine dependence in mental health settings.
        Journal of Practical Psychiatry and Behavioral Health. 2007; 3: 250-254
        • Himelhoch S.
        • Daumit G.
        To whom to psychiatrists offer smoking-cessation counseling?.
        Am J Psychiatry. 2003; 160: 2228-2230
        • Prochaska J.
        • DiClemente C.C.
        Stages and processes of self–change of smoking: toward an integrative model of change.
        J Consult Clin Psychol. 1983; 51: 390-395
        • Bobo J.K.
        • McIlvain H.E.
        • Gilchrist L.D.
        • Bowman A.
        Nicotine dependence and intentions to quit smoking in three samples of male and female recovering alcoholics and problem drinkers.
        Subst Use Misuse. 1996; 31: 17-33
        • Nahvi S.
        • Richter K.
        • Li X.
        • Modali L.
        • Arnsten J.
        Cigarette smoking and interest in quitting in methadone maintenance patients.
        Addict Behav. 2006; 31: 2127-2134
        • Hall R.G.
        • Duhamel M.
        • McClanahan R.
        • et al.
        Level of functioning, severity of illness, and smoking status among chronic psychiatric patients.
        J Nerv Ment Dis. 1995; 183: 468-471
        • Joseph A.M.
        • Willenbring M.L.
        • Nugent S.M.
        • Nelson D.B.
        A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment.
        J Stud Alcohol. 2004; 65: 681-692
        • Hall S.M.
        • Munoz R.F.
        • Reus V.I.
        Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers.
        J Consult Clin Psychol. 1994; 62: 141-146
        • Hall S.M.
        • Muñoz R.F.
        • Reus V.I.
        • et al.
        Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo–controlled study.
        J Consult Clin Psychol. 1996; 64: 1003-1009
        • Hall S.M.
        • Reus V.I.
        • Muñoz R.F.
        • et al.
        Nortriptyline and cognitive behavioral therapy in the treatment of cigarette smoking.
        Arch Gen Psychiatry. 1998; 55: 683-690
        • Haas A.L.
        • Munoz R.F.
        • Humfleet G.L.
        • Reus V.I.
        • Hall S.M.
        Influences of mood, depression history, and treatment modality on outcomes in smoking cessation.
        J Consult Clin Psychol. 2004; 72: 563-570
        • Brown R.A.
        • Kahler C.W.
        • Niaura R.
        • et al.
        Cognitive-behavioral treatment for depression in smoking cessation.
        J Consult Clin Psychol. 2001; 69: 471-480
        • Hall S.M.
        • Tsoh J.Y.
        • Prochaska J.J.
        • et al.
        Treatment for cigarette smoking among depressed mental health outpatients: A randomized clinical trial.
        Am J Public Health. 2006; 96: 1808-1814
        • Fiore M.C.
        Clinical practice guidelines for treating tobacco use and dependence: a U.S. Public Health Service report.
        JAMA. 2000; 283: 3244-3254
        • Hall S.M.
        • Humfleet G.L.
        • Reus V.I.
        • Muñoz R.F.
        • Cullen J.
        Extended nortriptyline and psychological treatment for cigarette smoking.
        Am J Psychiatry. 2004; 161: 2100-2107
        • Hall S.M.
        • Humfleet G.L.
        • Reus V.I.
        • Munoz R.F.
        • Hartz D.T.
        • Maude-Griffin R.
        Psychological intervention and antidepressant treatment in smoking cessation.
        Arch Gen Psychiatry. 2002; 59: 930-936
        • Prochazka A.V.
        • Kick S.
        • Steinbrunn C.
        • Miyoshi T.
        • Fryer G.E.
        A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
        Arch Intern Med. 2004; 164: 2229-2233
        • Tsoh J.
        • Humfleet G.
        • Munoz R.F.
        • Reus V.I.
        • Hartz D.T.
        • Hall S.M.
        Development of major depression following smoking cessation treatment.
        Am J Psychiatry. 2000; 157: 368-374
        • Glassman A.H.
        • Covey L.S.
        • Stetner F.
        • Rivelli S.
        Smoking cessation and the course of major depresion: a follow-up study.
        Lancet. 2001; 357: 1129-1132
        • Prochaska J.J.
        • Hall S.M.
        • Tsoh J.Y.
        • et al.
        Treating tobacco dependence in smokers with clinical depression: Impact on mental health functioning.
        Am J Public Health. 2007; (in press): 97
        • George T.P.
        • Vessicchio J.C.
        • Termine A.
        • et al.
        A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
        Biol Psychiatry. 2002; 52: 53-61
        • Evins A.E.
        • Cather C.
        • Deckersbach T.
        • et al.
        A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.
        J Clin Psychopharmacol. 2005; 25: 218-225
        • McFall M.
        • Saxon A.J.
        • Thompson C.E.
        • et al.
        Improving the rates of quitting smoking for veterans with posttraumatic stress disorder.
        Am J Psychiatry. 2005; 162: 1311-1319
        • Kohn C.S.
        • Tsoh J.Y.
        • Weisner C.M.
        Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up.
        Drug Alcohol Depend. 2003; 69: 61-71
        • Tercyak K.P.
        • Lerman C.
        • Audrain J.
        Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents.
        J Am Acad Child Adolesc Psychiatry. 2002; 41: 799-805
        • Biederman J.
        • Monuteaux M.C.
        • Mick E.
        • et al.
        Is cigarette smoking a gateway to alcohol and illicit drug use disorders?.
        Biol Psychiatry. 2006; 59: 258-264
        • Humfleet G.L.
        • Prochaska J.J.
        • Mengis M.
        • et al.
        Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.
        Nicotine Tob Res. 2005; 7: 453-460
        • Schuckit M.A.
        • Danko G.P.
        • Smith T.L.
        Patterns of drug-related disorders in a prospective study of men chosen for their family history of alcoholism.
        J Stud Alcohol. 2004; 65: 613-620
        • Prochaska J.O.
        • DiClemente C.C.
        • Velicer W.F.
        • Rossi J.S.
        Standardized, individualized, interactive, and personalized self-help programs for smoking cessation.
        Health Psychol. 1993; 12: 399-405
        • Prochaska J.O.
        • Velicer W.F.
        • Fava J.L.
        • Rossi J.S.
        • Tsoh J.Y.
        Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation.
        Addict Behav. 2001; 26: 583-602
        • George T.P.
        • Vessicchio J.
        • Allen T.
        • Weinberger A.
        • Sacco K.A.
        A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome.
        Neuropsychopharmacology. 2006; 31: S254-S255
        • Evins A.E.
        • Cather C.
        • Culhane M.
        Predictors of smoking cessation in patients with schizophrenia.
        Nicotine Tob Res. 2005; 7 (680–680)
        • Jorenby D.E.
        • Hays J.T.
        • Rigotti N.A.
        • et al.
        Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial.
        JAMA. 2006; 296: 56-63
        • Chassin L.
        • Presson C.
        • Morgan-Lopez A.
        • Sherman S.J.
        “Deviance proneness” and adolescent smoking 1980 versus 2001: Has there been a “hardening” of adolescent smoking?.
        J Appl Dev Psychol. 2007; 28: 264-276
        • Hughes J.R.
        • Brandon T.H.
        A softer view on hardening.
        Nicotine Tob Res. 2003; 5: 961-962
        • Irvin J.E.
        • Hendricks P.S.
        • Brandon T.H.
        The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials.
        Nicotine Tob Res. 2003; 5: 27-35
        • Warner K.E.
        • Burns D.M.
        Hardening and the hard-core smoker: concepts, evidence, and implications.
        Nicotine Tob Res. 2003; 5: 37-48
        • Kessler R.C.
        • Chiu W.T.
        • Demler O.
        • Merikangas K.R.
        • Walters E.E.
        Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. (published erratum appears in Arch Gen Psychiatry 2005;62:709).
        Arch Gen Psychiatry. 2005; 62: 617-627
        • Grant B.F.
        • Moore T.C.
        • Shepard J.
        • Kaplan K.
        Source andaAccuracy Statement: Wave 1.
        National Epidemiologic Survey on Alcohol and Related Conditions (NESARC): National Institute on Alcohol Abuse and Alcoholism. 2003
        • Compton W.M.
        • Thomas Y.F.
        • Stinson F.S.
        • Grant B.F.
        Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.
        Arch Gen Psychiatry. 2007; 64: 566-576